跳至主要内容
临床试验/CTRI/2023/01/048654
CTRI/2023/01/048654招募中3 期

Evaluation of comparative efficacy of Intralesional Apamarga Ksharodak versus Intralesional Cidofovir in the management of Charmakeela(Warts)

Datta Meghe Institute of Medical Science0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient willing with written informed consent as per Helsinki declaration.
  • 2. Age group of 17 to 70 years.
  • 3. Patients with clinical features of warts of painless , small ,rough and hard growth similar to skin .
  • 4. Patients irrespective of gender, occupation and economic status.

排除标准

  • 1. Uncontrolled and insulin dependent Diabetes Mellitus, Uncontrolled Hypertension , Tuberculosis, Carcinoma , Endocrine Disorders and Kidney or hepatic disorder.
  • 2. Sites of warts â?? sensitive places like : genitals, eye lids, lips, etc .
  • 3. History of anticoagulants and haemophilla.
  • 4. Pregnant and lactating females.
  • 5. Substantial abnormalities in hematological

研究者

发起方
Datta Meghe Institute of Medical Science

相似试验